Steve Barrett is a partner in the Technology Transactions and Licensing Group. He joined the firm in 1996.
Practice
Mr. Barrett's practice is primarily focused on technology-related agreements, including biotechnology and information technology development and license agreements and distribution, services and joint venture agreements.
Recent Highlights
Companies that Mr. Barrett has recently advised in licensing and collaboration matters include Aegera Therapeutics, Alnara Pharmaceuticals, Alnylam Pharmaceuticals, Alpharma, Antisoma, Braintree Laboratories, Bristol-Myers Squibb, Cephalon, Concert Pharmaceuticals, Epistem, Foamix, GT Solar, Icagen, Idera Pharmaceuticals, InfoMedics, The Medicines Company, Merrimack Pharmaceuticals, Mersana Therapeutics, Ophthotech, Potentia Pharamaceuticals, Presidio Pharmaceuticals, Silicon Integration Initiative and Wellstat Therapeutics.
Honors and Awards
- Recognized in the 2006/07, 2007/08, 2008/09 and 2009/2010 editions of the PLC Cross-border Life Sciences Handbook in the USA Commercial and Partnering category
- Named a "Massachusetts Super Lawyers' Rising Star" in intellectual property law in the May 2005 and May 2006 issues of Boston Magazine
Community Involvement
Mr. Barrett serves on the board of directors of The Political Asylum/Immigration Representation (PAIR) Project.